首页 > 最新文献

World journal of gastroenterology, hepatology and endoscopy最新文献

英文 中文
Articular Cartilage: Can Articular Cartilage be Considered a Smart Material? 关节软骨:关节软骨可以被认为是一种智能材料吗?
Pub Date : 2021-01-01 DOI: 10.47690/WJGHE.2021.3308
Zenon P, Michał S, Bozena K
It has been shown that the “smart surface” of cartilage is highly hydrophilic when wet and hydrophobic when air-dry. The minimum surface energy of the bilayer was found to spread over a wide range of pH (6.5 to 9.5). The decreased number of bilayers changed the wettability and lowered the PL lubricant properties. In conclusion, a cartilage smart material can significantly react to changes pH and moisture. The biological tissue of the articular cartilage (AC) is amphoteric in its natural condition transforming surface from the hydrophilic to hydrophobic in air-dry condition (Figure 1 a, b). The profiles of the interfacial surface energy (γ ) of spherical lipid bilayer model „bell-shaped curve” vs. pH change the surface charge from positive, neutral to negative, the articular cartilage can be named a “smart material” (Figure 1c). The understanding of AC amphoteric surface will be essential for understanding the joints lubrication mechanism, the effective repair and regeneration of the degraded knee joint. The isoelectric point, IEP, is at a pH of ~ 4 when a PL molecule carries no net electrical charge H2N (CH2)n PO4H-R1R2  H3N + (CH2)n PO4 -R1R2. Changes of the interfacial energy correspond to the amino (-NH3 +→ -NH2) transition with a low pH, after IEP the phosphate (-PO4H → -PO4 -) transition at a higher pH range of 4 to 6.5. The isoelectric point, IEP, with the pH at which a phospholipid molecule carries no net electrical charge. The wetted surfaces (pH~6.5 to 9.5) of the phospholipid membranes are negatively charged (–PO4 -). Biosurface wettability can be measured relative to the differences in the charge density of the functional phosphate (–PO4 -) group. In this regard, the wettability of a hydrated surface is characterized by the concentration of charged anionic phosphate (–PO4 -) groups that are deactivated when the surface is dehydrated. The dehydration of the phospholipid bilayer surface activates hydrophobic groups, R (CH2)n due to the formation World J Gastroenterol Hepatol Endosc Volume: 3.3 1/2 of a hydrophobic monolayer, Figure 1. The hydrophilic surface in the course of dehydration, for example, via air-drying, undergoes a slow increase in the wettability contact angle indicating conformational changes in the surface (flip-flop) phospholipid molecules. Poor lubrication in animal joints, particularly on the articular surface of cartilage, can be attributed to deterioration of the bilayer surface, where the wettability or contact angle (θ) changes from 104° to less than 70° (Wettability was measured in air-dry condition) (Figure 2). Figure 1 (a, b): The smart-surface constitution of superficial phospholipid bilayer of articular cartilage in (a) wet (hydrophilic) and (b) at air-dry condition (hydrophobic). Figuer 1(c): The profiles of the interfacial surface energy (γ ) of spherical lipid bilayer model “bell-shaped curve” vs. pH of buffer solution. (a) ( pH 0.2 to 4.0 (-NH3 +→ -NH2.). (b) (pH 4.0 to 6.5 ) (-PO4H → -PO4 -) IEP : H2N (C
研究表明,软骨的“智能表面”在潮湿时是高度亲水的,在风干时是疏水的。发现双分子层的最小表面能在很宽的pH范围内(6.5至9.5)分布。双分子层数量的减少改变了润湿性,降低了PL润滑油的性能。综上所述,软骨智能材料可以对pH值和湿度的变化做出显著的反应。关节软骨(AC)的生物组织在自然状态下是两性的,在风干条件下表面由亲水性变为疏水性(图1a, b)。球形脂质双层模型的界面表面能(γ)与pH值的“钟形曲线”变化使表面电荷从正、中性变为负,关节软骨可以被命名为“智能材料”(图1c)。了解AC两性表面对了解关节润滑机制、退化膝关节的有效修复和再生具有重要意义。当PL分子不带净电荷时,等电点IEP为~ 4,H2N (CH2)n PO4H-R1R2H3N + (CH2)n PO4 -R1R2。界面能的变化对应于低pH下的氨基(- nh3 +→- nh2)转变,IEP后的磷酸(- po4h→- po4 -)转变在更高的pH范围(4 ~ 6.5)。等电点,IEP,在该等电点上磷脂分子不带净电荷。磷脂膜的湿润表面(pH~6.5 ~ 9.5)带负电荷(- po4 -)。生物表面润湿性可以通过功能磷酸(- po4 -)基团的电荷密度差异来测量。在这方面,水合表面的润湿性是由带电的阴离子磷酸盐(- po4 -)基团的浓度表征的,这些基团在表面脱水时失活。磷脂双分子层表面的脱水激活疏水基团R (CH2)n,形成World J Gastroenterol Hepatol Endosc体积:疏水单层的3.3 /2,图1。亲水表面在脱水过程中,例如通过空气干燥,润湿性接触角缓慢增加,这表明表面磷脂分子的构象发生了变化(翻转)。动物关节的润滑不良,特别是软骨关节表面的润滑不良,可归因于双层表面的恶化,其中润湿性或接触角(θ)从104°变化到小于70°(润湿性在风干条件下测量)(图2)。图1 (a, b): (a)潮湿(亲水)和(b)风干条件下(疏水)关节软骨表面磷脂双层的智能表面构成。图1(c):球形脂质双层模型界面表面能(γ)随缓冲溶液pH的“钟形曲线”分布图。(a) (pH 0.2 ~ 4.0 (-NH3 +→-NH2)。(b) (pH 4.0 ~ 6.5) (- po4h→-PO4 -) IEP: H2N (CH2)n PO4H-R1R2H3N (CH2)n PO4 - r1r2图2:(A)软骨表面的亲水性模型(b)显示了软骨在潮湿条件下亲水性双层向疏水性单层(在风干室内条件下)的转变。片层排斥机制是由磷脂片层相和带负电荷的软骨表面之间的滑膜液中的带电大分子支持的。低摩擦是由于带负电荷的(- po4 -)软骨表面界面之间的短距离水合排斥(纳米级)和滑液中大分子的贡献,以及最重要的双层板层滑动的结果。磷脂双分子层的酸碱性质显著影响其润湿性和表面摩擦性能(图2)。综上所述,软骨智能材料可以对pH值和湿度的变化做出显著的反应。
{"title":"Articular Cartilage: Can Articular Cartilage be Considered a Smart Material?","authors":"Zenon P, Michał S, Bozena K","doi":"10.47690/WJGHE.2021.3308","DOIUrl":"https://doi.org/10.47690/WJGHE.2021.3308","url":null,"abstract":"It has been shown that the “smart surface” of cartilage is highly hydrophilic when wet and hydrophobic when air-dry. The minimum surface energy of the bilayer was found to spread over a wide range of pH (6.5 to 9.5). The decreased number of bilayers changed the wettability and lowered the PL lubricant properties. In conclusion, a cartilage smart material can significantly react to changes pH and moisture. The biological tissue of the articular cartilage (AC) is amphoteric in its natural condition transforming surface from the hydrophilic to hydrophobic in air-dry condition (Figure 1 a, b). The profiles of the interfacial surface energy (γ ) of spherical lipid bilayer model „bell-shaped curve” vs. pH change the surface charge from positive, neutral to negative, the articular cartilage can be named a “smart material” (Figure 1c). The understanding of AC amphoteric surface will be essential for understanding the joints lubrication mechanism, the effective repair and regeneration of the degraded knee joint. The isoelectric point, IEP, is at a pH of ~ 4 when a PL molecule carries no net electrical charge H2N (CH2)n PO4H-R1R2  H3N + (CH2)n PO4 -R1R2. Changes of the interfacial energy correspond to the amino (-NH3 +→ -NH2) transition with a low pH, after IEP the phosphate (-PO4H → -PO4 -) transition at a higher pH range of 4 to 6.5. The isoelectric point, IEP, with the pH at which a phospholipid molecule carries no net electrical charge. The wetted surfaces (pH~6.5 to 9.5) of the phospholipid membranes are negatively charged (–PO4 -). Biosurface wettability can be measured relative to the differences in the charge density of the functional phosphate (–PO4 -) group. In this regard, the wettability of a hydrated surface is characterized by the concentration of charged anionic phosphate (–PO4 -) groups that are deactivated when the surface is dehydrated. The dehydration of the phospholipid bilayer surface activates hydrophobic groups, R (CH2)n due to the formation World J Gastroenterol Hepatol Endosc Volume: 3.3 1/2 of a hydrophobic monolayer, Figure 1. The hydrophilic surface in the course of dehydration, for example, via air-drying, undergoes a slow increase in the wettability contact angle indicating conformational changes in the surface (flip-flop) phospholipid molecules. Poor lubrication in animal joints, particularly on the articular surface of cartilage, can be attributed to deterioration of the bilayer surface, where the wettability or contact angle (θ) changes from 104° to less than 70° (Wettability was measured in air-dry condition) (Figure 2). Figure 1 (a, b): The smart-surface constitution of superficial phospholipid bilayer of articular cartilage in (a) wet (hydrophilic) and (b) at air-dry condition (hydrophobic). Figuer 1(c): The profiles of the interfacial surface energy (γ ) of spherical lipid bilayer model “bell-shaped curve” vs. pH of buffer solution. (a) ( pH 0.2 to 4.0 (-NH3 +→ -NH2.). (b) (pH 4.0 to 6.5 ) (-PO4H → -PO4 -) IEP : H2N (C","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76721723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric Varices Treatment: Is it Possible to Individualise Therapy for Bleeding Patients 胃静脉曲张治疗:出血患者是否可能个体化治疗
Pub Date : 2021-01-01 DOI: 10.47690/WJGHE.2021.3307
Jamwal Kd
REVIEW Gastric Varices (GV) are present in 15-25% of cirrhotics with GOV1 and the primary gastric varices being the most common [1]. Gastric varices can also be present in patients with left sided portal hypertension. As compared to esophageal varices the incidence of gastric variceal bleeding is low (10-20%) and bleeding is not proportional to portal pressure as is noted in esophageal varices, with a re bleeding rate of 30% in GV [2,3]. The GV bleeding is difficult to control due to presence of a thick mucosal layer over the GV, which does not collapse after bleeding. With the advent of hemo dynamic studies in GV, there has been change in approach to management of GV. Recently there has been increased focus on individualised GV treatment based on hemo dynamics of the portal system, especially on the left sided venous diseases (GV, ectopic varices, lieno renal shunt) and not on traditionally based endoscopic appearance as is done in most of the cases worldwide. With a contrast CT scan of the portal venous system, it is easy to delineate the anatomy prior to planning a definitive treatment (either primary or secondary). At present the standard treatment for GV is endoscopic glue injection (EGI) by an endoscopist and BRTO (balloon retrograde trans venous obliteration) via intervention radiologist [4-8]. Technically BRTO seems more complete when compared to an EGI, because the whole shunt which drains the GV is taken care of by the BRTO procedure. Whereas in the EGI procedure, only the mucosal varices are treated and the remaining sub mucosal varices, the shunt and the draining pathways (both afferent and efferent) are left untreated. An endoscopic ultrasound (EUS) is a much superior modality of managing vascular disorders such as GV, a. it has col our doppler b. it can differentiate between an artery & a vein c. it can assess shunts & collaterals d. it can assess completion of therapy [9,10]. EUS has been used for treatment of GV from the last decade and it has shown to be technically superior, safe and also it decreases overall cost, number of sessions and morbidity related to re bleeding in GV. With the advent of better diagnostic imaging of the portal venous anatomy such as CT/ MR venography the venous drainage and collaterals can be delineated in patients with GV, this knowledge of the anatomy when combined treatment modalities such as EGI, BRTO or EUS guided vascular treatment helps in individualising the therapy for the patients with GV. In patients of GV with significant collaterals and shunts on the left side of mid line such as (afferent collateralsposterior gastric vein, short
15-25%的肝硬化GOV1患者存在胃静脉曲张(GV),其中原发性胃静脉曲张是最常见的[1]。左侧门静脉高压患者也可出现胃静脉曲张。与食管静脉曲张相比,胃静脉曲张出血的发生率较低(10-20%),出血与食管静脉曲张的门静脉压力不成比例,胃静脉曲张再出血率为30%[2,3]。上消化道出血是难以控制的,因为上消化道有一层厚的粘膜层,出血后粘膜层不会塌陷。随着GV血液动力学研究的出现,GV的治疗方法也发生了变化。最近,越来越多的人关注基于门静脉系统血流动力学的个体化静脉曲张治疗,特别是针对左侧静脉疾病(静脉曲张、异位静脉曲张、静脉肾分流),而不是像世界上大多数病例那样基于传统的内窥镜检查。通过门静脉系统的CT对比扫描,很容易在计划最终治疗(原发性或继发性)之前划定解剖结构。目前GV的标准治疗是内镜医师进行内镜下胶注射(EGI),介入放射科医师进行球囊逆行经静脉闭塞术(BRTO)[4-8]。从技术上讲,与EGI相比,BRTO似乎更完整,因为排出GV的整个分流是由BRTO程序处理的。而在EGI手术中,只治疗粘膜静脉曲张,其余的粘膜下静脉曲张、分流和引流通路(传入和传出)不治疗。内镜超声(EUS)是治疗血管疾病(如GV)的一种更优越的方式,a.它具有低多普勒b.它可以区分动脉和静脉c.它可以评估分流和侧支d.它可以评估治疗的完成情况[9,10]。在过去的十年中,EUS被用于治疗GV,它已被证明在技术上更优越、更安全,而且它降低了GV再出血的总成本、治疗次数和发病率。随着更好的门静脉解剖诊断成像(如CT/ MR静脉造影)的出现,静脉引流和侧支可以在GV患者中描绘出来,这种解剖学知识可以在联合治疗方式(如EGI, BRTO或EUS引导的血管治疗)中帮助个体化治疗GV患者。在中线左侧有明显侧支和分流的GV患者,如传入侧支胃后静脉,短
{"title":"Gastric Varices Treatment: Is it Possible to Individualise Therapy for Bleeding Patients","authors":"Jamwal Kd","doi":"10.47690/WJGHE.2021.3307","DOIUrl":"https://doi.org/10.47690/WJGHE.2021.3307","url":null,"abstract":"REVIEW Gastric Varices (GV) are present in 15-25% of cirrhotics with GOV1 and the primary gastric varices being the most common [1]. Gastric varices can also be present in patients with left sided portal hypertension. As compared to esophageal varices the incidence of gastric variceal bleeding is low (10-20%) and bleeding is not proportional to portal pressure as is noted in esophageal varices, with a re bleeding rate of 30% in GV [2,3]. The GV bleeding is difficult to control due to presence of a thick mucosal layer over the GV, which does not collapse after bleeding. With the advent of hemo dynamic studies in GV, there has been change in approach to management of GV. Recently there has been increased focus on individualised GV treatment based on hemo dynamics of the portal system, especially on the left sided venous diseases (GV, ectopic varices, lieno renal shunt) and not on traditionally based endoscopic appearance as is done in most of the cases worldwide. With a contrast CT scan of the portal venous system, it is easy to delineate the anatomy prior to planning a definitive treatment (either primary or secondary). At present the standard treatment for GV is endoscopic glue injection (EGI) by an endoscopist and BRTO (balloon retrograde trans venous obliteration) via intervention radiologist [4-8]. Technically BRTO seems more complete when compared to an EGI, because the whole shunt which drains the GV is taken care of by the BRTO procedure. Whereas in the EGI procedure, only the mucosal varices are treated and the remaining sub mucosal varices, the shunt and the draining pathways (both afferent and efferent) are left untreated. An endoscopic ultrasound (EUS) is a much superior modality of managing vascular disorders such as GV, a. it has col our doppler b. it can differentiate between an artery & a vein c. it can assess shunts & collaterals d. it can assess completion of therapy [9,10]. EUS has been used for treatment of GV from the last decade and it has shown to be technically superior, safe and also it decreases overall cost, number of sessions and morbidity related to re bleeding in GV. With the advent of better diagnostic imaging of the portal venous anatomy such as CT/ MR venography the venous drainage and collaterals can be delineated in patients with GV, this knowledge of the anatomy when combined treatment modalities such as EGI, BRTO or EUS guided vascular treatment helps in individualising the therapy for the patients with GV. In patients of GV with significant collaterals and shunts on the left side of mid line such as (afferent collateralsposterior gastric vein, short","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"120 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87931253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Compliance on Directly Acting Oral Antiviral in Hcv Patients 丙型肝炎患者口服抗病毒药物的依从性
Pub Date : 2021-01-01 DOI: 10.47690/WJGHE.2021.3403
M. Parveen, M. Vani, G. Usha, Paramjeet Sg, Pushkar, S. Yogesh, Akshay
INTRODUCTION: Chronic hepatitis C is one of the most common cause all over the world for causing cirrhosis of liver and thus requiring liver transplantation as the definitive treatment which is beyond reach in most of patients in developing countries. The availability of oral directly acting antiviral for treatment in India since 2015 has changed the scenario due to its good compliance among the patients. AIMS AND OBJECTIVES: To determine the compliance among patients who were treated with directly acting oral antiviral drugs for Hepatitis C (Sofosbuvir 400 mg, Daclastavir 60 mg, Velpatasvir 100 mg). MATERIALS AND METHODS: It was prospective study conducted at Department of Medical Gastroenterology, Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, over a period of five years from 01.01.2016 to 31.12.2020. Out of four thousand patients of Chronic hepatitis C who reported in department in above five years duration, 570 patients pre therapy HCV RNA was not detected, hence they were not treated and were not part of the study. Out of the remaining 3430 patients, 130 patients went for alternative medications and hence were excluded from the study. The remaining 3300 confirmed patients of Chronic hepatitis C who were started on treatment with oral antiviral drugs were followed till they completed their treatment. Out of these 3300 patients,10 patients who were cirrhotic died during their course of treatment, hence in final analysis 3290 patients were included. RESULTS: Only ten patients out of total pool of 3290 left medicines due to side effects, thus high compliance rate of 99.69% was achieved.
慢性丙型肝炎是全世界导致肝硬化的最常见原因之一,因此需要肝移植作为最终治疗,这在发展中国家的大多数患者中是无法实现的。自2015年以来,印度口服直接作用抗病毒药物的可用性改变了这种情况,因为它在患者中具有良好的依从性。目的和目的:确定直接作用口服丙型肝炎抗病毒药物(索非布韦400 mg, daclastavi60 mg, Velpatasvir 100 mg)治疗的患者的依从性。材料与方法:前瞻性研究于2016年1月1日至2020年12月31日在Rohtak医学科学研究生院(PGIMS)医学消化内科进行,为期5年。在住院5年以上的4000名慢性丙型肝炎患者中,570名患者在治疗前未检测到HCV RNA,因此他们没有接受治疗,也没有参与研究。在剩下的3430名患者中,有130名患者接受了替代药物治疗,因此被排除在研究之外。其余3300名开始接受口服抗病毒药物治疗的慢性丙型肝炎确诊患者接受随访,直到他们完成治疗。在这3300名患者中,10名肝硬化患者在治疗过程中死亡,因此最终分析纳入了3290名患者。结果:3290例患者中,仅有10例患者因不良反应留下用药,用药依从率高达99.69%。
{"title":"Compliance on Directly Acting Oral Antiviral in Hcv Patients","authors":"M. Parveen, M. Vani, G. Usha, Paramjeet Sg, Pushkar, S. Yogesh, Akshay","doi":"10.47690/WJGHE.2021.3403","DOIUrl":"https://doi.org/10.47690/WJGHE.2021.3403","url":null,"abstract":"INTRODUCTION: Chronic hepatitis C is one of the most common cause all over the world for causing cirrhosis of liver and thus requiring liver transplantation as the definitive treatment which is beyond reach in most of patients in developing countries. The availability of oral directly acting antiviral for treatment in India since 2015 has changed the scenario due to its good compliance among the patients. AIMS AND OBJECTIVES: To determine the compliance among patients who were treated with directly acting oral antiviral drugs for Hepatitis C (Sofosbuvir 400 mg, Daclastavir 60 mg, Velpatasvir 100 mg). MATERIALS AND METHODS: It was prospective study conducted at Department of Medical Gastroenterology, Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, over a period of five years from 01.01.2016 to 31.12.2020. Out of four thousand patients of Chronic hepatitis C who reported in department in above five years duration, 570 patients pre therapy HCV RNA was not detected, hence they were not treated and were not part of the study. Out of the remaining 3430 patients, 130 patients went for alternative medications and hence were excluded from the study. The remaining 3300 confirmed patients of Chronic hepatitis C who were started on treatment with oral antiviral drugs were followed till they completed their treatment. Out of these 3300 patients,10 patients who were cirrhotic died during their course of treatment, hence in final analysis 3290 patients were included. RESULTS: Only ten patients out of total pool of 3290 left medicines due to side effects, thus high compliance rate of 99.69% was achieved.","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"127 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80231887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal bezoar on peptic stenosis in a 7-year-old child 食管牛黄治疗7岁儿童消化性狭窄
Pub Date : 2021-01-01 DOI: 10.47690/wjghe.2021.3605
B. O., Meskini T, Berrani H, S. M, E. S, M. N
The term bezoar refers to foreign bodies found in the digestive tract. It results in a stagnation of ingested non-digestible substances. We report a case of an esophageal bezoar collected in the pediatric gastroenterology department of the children's hospital in RabatMOROCCO. This observation of an esophageal bezoar, the first in our institution, to our knowledge, confirms the rarity of the pathology. 7-year-old child, taken by his parents to the children's hospital of the university hospital in Rabat for total aphagia. His history shows: psychomotor retardation, followed for 2 years for peptic esophagitis complicated by peptic stenosis. The course was marked by total aphagia, early postprandial vomiting, and weight loss of 6 kg in 3 months. This symptomatology has been evolving for 2 months. Esophagogastroduodenal fibroscopy, using an 8.5mm pediatric fiberscope, revealed an esophageal bezoar made of tissues, fibers, hair, sponge, plastics and ropes. A multistage endoscopic extraction was performed, which extracted a 430g bezoar. After a complete cleansing of the esophagus, the esophagogastroduodenal exploration showed ascension of the gastric folds on retrovision, a gaping cardia, a hernial pouch, an esophageal caliber disparity of 25 cm to 20 cm of the dental arches with presence of mucous ulcerations and false membranes. After extraction, the child resumed his normal diet with no vomiting. a proton pump inhibitor and antibiotic therapy were prescribed. INTRODUCTION The term bezoar refers to foreign bodies found in the digestive tract. It results in a stagnation of ingested non-digestible substances, such as hair (trichobezoar), certain vegetable fibers (phytobezoar), concentrated dairy products (lactobezoar), more rarely certain drugs (pharmacobezoar). Its esophageal location is little reported in the literature, it is often secondary to a morphological and / or functional abnormality of the esophagus and is frequently involved. It usually concerns children or young adolescents with mental disorders [1]. We report a case of an esophageal bezoar collected in the pediatric gastroenterology department of the children's hospital in RabatMOROCCO. This observation of an esophageal bezoar, the first in our institution, to our knowledge, confirms the rarity of the pathology. PATIENT AND OBSERVATION 7-year-old child, taken by his parents to the children's hospital of the university hospital in Rabat for total aphagia. His history shows: psychomotor retardation, followed for 2 years for peptic esophagitis complicated by peptic stenosis. The course was marked by total aphagia, early postprandial vomiting, and weight loss of 6 kg in 3 months. This symptomatology has been evolving for 2 months. The admission exam noted: a pale patient. A weight of 12kg (3 DS), a height of 114cm (2DS). World J Gastroenterol Hepatol Endosc Volume: 3.6 1/3 Received Date: 10 Oct 2021 Accepted Date: 16 Oct 2021 Published Date: 22 Oct 2021 The biological assessment showed on the
牛黄是指在消化道中发现的异物。它会导致摄入的不可消化物质停滞不前。我们报告一例食道牛黄收集在儿童医院儿科消化内科在拉巴特摩洛哥。据我们所知,这是本院首次观察到食管牛黄,证实了这种病理的罕见性。7岁儿童,被父母带到拉巴特大学医院的儿童医院治疗完全失语症。病史显示:精神运动迟缓,消化性食管炎合并消化性狭窄,随访2年。整个疗程的特点是完全失语,早期餐后呕吐,3个月内体重减轻6公斤。这种症状已经发展了2个月。食管胃十二指肠纤维镜,使用8.5mm儿童纤维镜,发现由组织、纤维、头发、海绵、塑料和绳索组成的食管牛黄。进行多级内镜提取,提取430g牛黄。完全清洁食道后,食道-胃十二指肠探查显示逆行胃褶上升,贲门开口,疝囊,食道口径相差25厘米至20厘米,牙弓存在粘膜溃疡和假膜。拔牙后,患儿恢复正常饮食,无呕吐。给予质子泵抑制剂和抗生素治疗。牛黄是指在消化道中发现的异物。它导致摄入的不可消化物质停滞不前,如头发(毛牛黄),某些植物纤维(植物牛黄),浓缩乳制品(乳牛黄),更罕见的是某些药物(药牛黄)。它的食道位置在文献中很少报道,它通常继发于食管的形态和/或功能异常,并且经常累及。它通常涉及患有精神障碍的儿童或青少年[1]。我们报告一例食道牛黄收集在儿童医院儿科消化内科在拉巴特摩洛哥。据我们所知,这是本院首次观察到食管牛黄,证实了这种病理的罕见性。患者与观察7岁儿童,由父母带到拉巴特大学医院的儿童医院治疗完全失语症。病史显示:精神运动迟缓,消化性食管炎合并消化性狭窄,随访2年。整个疗程的特点是完全失语,早期餐后呕吐,3个月内体重减轻6公斤。这种症状已经发展了2个月。入院检查记录:一个脸色苍白的病人。体重12公斤(3ds),身高114厘米(2DS)。世界杂志胃肠醇肝醇内皮体积:3.6 1/3接收日期:2021年10月10日接收日期:2021年10月16日发表日期:2021年10月22日血液计数生物学评估显示:血红蛋白6.3 g / dL,红细胞指数倾向于小细胞性低色素贫血,白细胞15200 / mm3,多形核细胞12200 / mm3,淋巴细胞2000 / mm3。血糖、CRP均在标准范围内。食管胃十二指肠纤维镜,使用8.5mm儿童纤维镜,发现由组织、纤维、毛发、海绵、塑料和绳索组成的食管牛黄(图1)。进行多级内镜提取,提取430g牛黄(图2)。食管胃十二指肠探查显示逆行胃皱襞上升(图3),贲门开口,疝囊,食管胃粘膜,食管胃粘膜。食管口径相差25厘米至20厘米的牙弓,存在粘膜溃疡和假膜(图4)。拔牙后,儿童恢复正常饮食,无呕吐。给予质子泵抑制剂和抗生素治疗。图1:食管牛黄的内镜图像。图2:内镜下牛黄提取图3:内镜图像显示胃褶皱上升,贲门开口,疝囊。图4:食管炎伴食管消化性狭窄的内镜影像。牛黄在儿童中少见,仅占胃肠道异物的0.15%。胃定位是最常见的。本病例的特殊之处在于食道的位置,通常是不寻常和不被认识的。在我们的病例中,精神运动迟缓经常出现在心理疾病患者中。[2]. 食管牛黄可分为发生在食道的原发性牛黄和胃牛黄迁移至食道的继发性牛黄[3]。
{"title":"Esophageal bezoar on peptic stenosis in a 7-year-old child","authors":"B. O., Meskini T, Berrani H, S. M, E. S, M. N","doi":"10.47690/wjghe.2021.3605","DOIUrl":"https://doi.org/10.47690/wjghe.2021.3605","url":null,"abstract":"The term bezoar refers to foreign bodies found in the digestive tract. It results in a stagnation of ingested non-digestible substances. We report a case of an esophageal bezoar collected in the pediatric gastroenterology department of the children's hospital in RabatMOROCCO. This observation of an esophageal bezoar, the first in our institution, to our knowledge, confirms the rarity of the pathology. 7-year-old child, taken by his parents to the children's hospital of the university hospital in Rabat for total aphagia. His history shows: psychomotor retardation, followed for 2 years for peptic esophagitis complicated by peptic stenosis. The course was marked by total aphagia, early postprandial vomiting, and weight loss of 6 kg in 3 months. This symptomatology has been evolving for 2 months. Esophagogastroduodenal fibroscopy, using an 8.5mm pediatric fiberscope, revealed an esophageal bezoar made of tissues, fibers, hair, sponge, plastics and ropes. A multistage endoscopic extraction was performed, which extracted a 430g bezoar. After a complete cleansing of the esophagus, the esophagogastroduodenal exploration showed ascension of the gastric folds on retrovision, a gaping cardia, a hernial pouch, an esophageal caliber disparity of 25 cm to 20 cm of the dental arches with presence of mucous ulcerations and false membranes. After extraction, the child resumed his normal diet with no vomiting. a proton pump inhibitor and antibiotic therapy were prescribed. INTRODUCTION The term bezoar refers to foreign bodies found in the digestive tract. It results in a stagnation of ingested non-digestible substances, such as hair (trichobezoar), certain vegetable fibers (phytobezoar), concentrated dairy products (lactobezoar), more rarely certain drugs (pharmacobezoar). Its esophageal location is little reported in the literature, it is often secondary to a morphological and / or functional abnormality of the esophagus and is frequently involved. It usually concerns children or young adolescents with mental disorders [1]. We report a case of an esophageal bezoar collected in the pediatric gastroenterology department of the children's hospital in RabatMOROCCO. This observation of an esophageal bezoar, the first in our institution, to our knowledge, confirms the rarity of the pathology. PATIENT AND OBSERVATION 7-year-old child, taken by his parents to the children's hospital of the university hospital in Rabat for total aphagia. His history shows: psychomotor retardation, followed for 2 years for peptic esophagitis complicated by peptic stenosis. The course was marked by total aphagia, early postprandial vomiting, and weight loss of 6 kg in 3 months. This symptomatology has been evolving for 2 months. The admission exam noted: a pale patient. A weight of 12kg (3 DS), a height of 114cm (2DS). World J Gastroenterol Hepatol Endosc Volume: 3.6 1/3 Received Date: 10 Oct 2021 Accepted Date: 16 Oct 2021 Published Date: 22 Oct 2021 The biological assessment showed on the","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84554403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pilot experience of non-invasive delivery of radiofrequency energy in patients with pelvic hypertonia. A novel second-generation technology 无创射频能量输送治疗盆腔高张力的试验经验。一种新的第二代技术
Pub Date : 2021-01-01 DOI: 10.15761/ghe.1000216
C. Salvemini, Elena G. Bertozzi, E. Virgilio, M. Raichi
{"title":"Pilot experience of non-invasive delivery of radiofrequency energy in patients with pelvic hypertonia. A novel second-generation technology","authors":"C. Salvemini, Elena G. Bertozzi, E. Virgilio, M. Raichi","doi":"10.15761/ghe.1000216","DOIUrl":"https://doi.org/10.15761/ghe.1000216","url":null,"abstract":"","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83511772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-invasive delivery of radiofrequency energy in women with faecal incontinence, the new era. The new-generation DQRF™ device 无创射频能量输送在女性大小便失禁中的新时代。新一代DQRF™器件
Pub Date : 2021-01-01 DOI: 10.15761/ghe.1000215
C. Salvemini, Elena G. Bertozzi, E. Virgilio, M. Raichi
{"title":"Non-invasive delivery of radiofrequency energy in women with faecal incontinence, the new era. The new-generation DQRF™ device","authors":"C. Salvemini, Elena G. Bertozzi, E. Virgilio, M. Raichi","doi":"10.15761/ghe.1000215","DOIUrl":"https://doi.org/10.15761/ghe.1000215","url":null,"abstract":"","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"114 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77704492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory Variceal Bleeding: Approach To Management (Mini Review) 难治性静脉曲张出血的处理方法(综述)
Pub Date : 2021-01-01 DOI: 10.47690/WJGHE.2021.3309
Short Review Acute variceal bleeding (AVB) is seen in 50-70% of patients with cirrhosis & portal hypertension (PHT) [1]. Over the time the severity of the bleeding and complications related to bleeding have significantly reduced due to improvement in clinical management, better availability of vasopressor drugs, improved endoscopic therapies as well as due to availability of definitive treatment options such as TIPS and liver transplantation. About 10-20% patients do not respond to initial management (failure to control bleeding within 48 hrs) and develop re bleeding within 5 days of starting the therapy (initial control of bleeding), these patients can be defined to have refractory variceal bleeding. The causes for refractory variceal bleeding are a. severe liver disease (high MELD-Na and CTP score) b. coagulopathy (increased PT, INR and low platelets) c. post EVL band ulcers (PEBU’s) or slippage of bands [2-4]. Failure to control bleeding leads to poorer outcome due to a. worsening liver failure b. development of organ dysfunction due to hypovolemia and progressive shock c. systemic sepsis and increased gut translocation of bacteria. The management in this group of patients depends upon the general condition of the patient and the liver disease status. There was a recent study which showed that endoscopic appearance of the varices after banding can determine the outcomes in addition to MELDNa score [4]. I. Generalized treatment for stabilization of the patient: a. This includes blood transfusion (packed red blood cell) to maintain a hemoglobin level of 7-8 gram / dl. The restrictive vs liberal treatment has shown that the restrictive strategy was better in terms of rebleeding and mortality [5]. b. The patients with coagulopathy can be treated either with blood products based on lab parameters (INR, platelet count, aPTT) or blood products based on TEG (thromboelastography). The conventional approach in coagulopathy with variceal bleeding is blood component based correction but the data does not support use of blood products in AVB. A recent RCT was done in cirrhotics with GI bleeding and cogulopathy, the patients had a non variceal bleeding source and were managed with TEG guided corrections in comparison to standard INR guided corrections. The study concluded that TEG based correction showed significant reduction in number of blood products
急性静脉曲张出血(AVB)见于50-70%的肝硬化和门静脉高压(PHT)患者[1]。随着时间的推移,由于临床管理的改善、血管加压药物的改善、内窥镜治疗的改进以及TIPS和肝移植等明确治疗方案的可用性,出血和出血相关并发症的严重程度已显著降低。约10-20%的患者对初始治疗无反应(48小时内未能控制出血),并在开始治疗后5天内再次出血(初步控制出血),这些患者可定义为难治性静脉曲张出血。难治性静脉曲张出血的原因有:a.严重的肝脏疾病(MELD-Na和CTP评分高)b.凝血功能障碍(PT、INR升高和血小板减少)c. EVL后带溃疡(PEBU’s)或带滑脱[2-4]。由于a.肝功能衰竭恶化b.低血容量和进行性休克导致器官功能障碍c.全身性败血症和肠道细菌易位增加,出血控制失败导致预后较差。这组患者的处理取决于患者的一般情况和肝脏疾病状况。最近有一项研究表明,除了MELDNa评分外,内窥镜下静脉曲张的外观也可以决定预后[4]。1 .稳定患者的综合治疗:a.包括输血(填充红细胞)以维持7-8克/分升的血红蛋白水平。限制性治疗与自由治疗对比表明,在再出血和死亡率方面,限制性治疗效果更好[5]。b.凝血功能障碍患者可以使用基于实验室参数(INR、血小板计数、aPTT)的血液制品或基于TEG(血栓弹性成像)的血液制品进行治疗。凝血病合并静脉曲张出血的传统方法是基于血液成分的校正,但数据不支持在AVB中使用血液制品。最近的一项随机对照试验对伴有消化道出血和神经病变的肝硬化患者进行了研究,这些患者有非静脉曲张出血来源,与标准的INR引导矫正相比,采用了TEG引导矫正。该研究的结论是,基于TEG的校正显示了血液制品数量的显著减少
{"title":"Refractory Variceal Bleeding: Approach To Management (Mini Review)","authors":"","doi":"10.47690/WJGHE.2021.3309","DOIUrl":"https://doi.org/10.47690/WJGHE.2021.3309","url":null,"abstract":"Short Review Acute variceal bleeding (AVB) is seen in 50-70% of patients with cirrhosis & portal hypertension (PHT) [1]. Over the time the severity of the bleeding and complications related to bleeding have significantly reduced due to improvement in clinical management, better availability of vasopressor drugs, improved endoscopic therapies as well as due to availability of definitive treatment options such as TIPS and liver transplantation. About 10-20% patients do not respond to initial management (failure to control bleeding within 48 hrs) and develop re bleeding within 5 days of starting the therapy (initial control of bleeding), these patients can be defined to have refractory variceal bleeding. The causes for refractory variceal bleeding are a. severe liver disease (high MELD-Na and CTP score) b. coagulopathy (increased PT, INR and low platelets) c. post EVL band ulcers (PEBU’s) or slippage of bands [2-4]. Failure to control bleeding leads to poorer outcome due to a. worsening liver failure b. development of organ dysfunction due to hypovolemia and progressive shock c. systemic sepsis and increased gut translocation of bacteria. The management in this group of patients depends upon the general condition of the patient and the liver disease status. There was a recent study which showed that endoscopic appearance of the varices after banding can determine the outcomes in addition to MELDNa score [4]. I. Generalized treatment for stabilization of the patient: a. This includes blood transfusion (packed red blood cell) to maintain a hemoglobin level of 7-8 gram / dl. The restrictive vs liberal treatment has shown that the restrictive strategy was better in terms of rebleeding and mortality [5]. b. The patients with coagulopathy can be treated either with blood products based on lab parameters (INR, platelet count, aPTT) or blood products based on TEG (thromboelastography). The conventional approach in coagulopathy with variceal bleeding is blood component based correction but the data does not support use of blood products in AVB. A recent RCT was done in cirrhotics with GI bleeding and cogulopathy, the patients had a non variceal bleeding source and were managed with TEG guided corrections in comparison to standard INR guided corrections. The study concluded that TEG based correction showed significant reduction in number of blood products","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"107 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77450341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Robotic Colonoscopy Endotics with Colon Wash: Two Performing Technologies in a Winning Combination 机器人结肠镜内窥镜与结肠清洗:两种表演技术的胜利组合
Pub Date : 2021-01-01 DOI: 10.47690/WJGHE.2021.3401
F. Cosentino, A. Rigante, R. Barbera, R. Giuberti, R. Tinelli, S. Zanardi
BACKGROUND: Colonoscopy is the standard method for CCR prevention, diagnosis, and treatment, but it is painful and highly dependent on quality of bowel preparation. This study describes the experience of the first 150 colonoscopies performed using the Endotics System at S. Giuseppe Hospital in Milan (Italy), demonstrating the effectiveness, diagnostic quality, and lack of pain even without sedation. Moreover, at the patient's request, robotic system was combined with Colon Wash technology, able to prepare the bowel in a comfortable and effective way without use of purgatives. METHODS: The study is observational, retrospective, comparative, on a group of 150 patients, enrolled consecutively over a year. Quality of the intestinal preparation is evaluated and then reported based on BBPS for both patients who underwent Colon Wash and those who opted for the traditional preparation. In addition, the total percentage of cecal intubation and the average time needed to achieve it, in patients who have also undergone Colon Wash, are reported. RESULTS: 87 out of the 150 patients enrolled, (58%) chose intestinal preparation with Colon Wash technology. In this group, optimal preparation was obtained in 71.3% of cases. The percentage of optimal preparation among patients who chose the traditional method decreased 66.7%. Failure rates of procedure due to poor bowel preparation were 4.6% and 3.2% respectively. Cecum was achieved in 99.2% of cases with an average time of 22.5 minutes. In addition, in patients with a previous failed conventional colonoscopy, cecum was achieved in 92.3% of cases. 58 patients out of the 150 were eligible for the ADR calculation according to the ASGE guidelines, resulting in an overall ADR of 39.7% (ADR M of 60% and ADR F of 24.2%). CONCLUSIONS: Endotics system confirms its ability to perform painless procedures as effectively as conventional colonoscopy (and Journal Home: https://scienceworldpublishing.org/journals/world-journal-of-gastroenterology-hepatology-and-endoscopy/WJGHE World J Gastroenterol Hepatol Endosc Volume: 3.4 2/9 more effectively in difficult cases). Colon Wash technology allows intestinal preparation comparable to the standard one. The combination of these two technologies can increase acceptance of colonoscopy procedure and adherence to CCR screening programs.
背景:结肠镜检查是预防、诊断和治疗CCR的标准方法,但它是痛苦的,并且高度依赖于肠道准备的质量。本研究描述了意大利米兰S. Giuseppe医院使用内镜系统进行的前150例结肠镜检查的经验,证明了其有效性、诊断质量和即使在没有镇静的情况下也没有疼痛。此外,在患者的要求下,机器人系统与结肠清洗技术相结合,能够在不使用泻药的情况下以舒适有效的方式准备肠道。方法:本研究采用观察性、回顾性、比较性研究,共纳入150例患者,连续入组一年以上。评估肠道准备的质量,然后根据BBPS对接受结肠清洗和选择传统准备的患者进行报告。此外,报告了盲肠插管的总百分比和完成插管所需的平均时间,这些患者也接受了结肠冲洗。结果:入组的150例患者中有87例(58%)选择使用结肠冲洗技术进行肠道准备。在该组中,71.3%的病例获得最佳制剂。选择传统方法的患者中最佳制剂的比例下降了66.7%。由于肠道准备不良导致的手术失败率分别为4.6%和3.2%。99.2%的病例达到盲肠,平均时间为22.5分钟。此外,在既往常规结肠镜检查失败的患者中,盲肠检查成功率为92.3%。根据ASGE指南,150例患者中有58例符合ADR计算标准,总体ADR为39.7% (ADR M为60%,ADR F为24.2%)。结论:内镜系统证实其能够像传统结肠镜检查一样有效地进行无痛手术(Journal Home: https://scienceworldpublishing.org/journals/world-journal-of-gastroenterology-hepatology-and-endoscopy/WJGHE World J Gastroenterol Hepatol Endosc Volume: 3.4 2/9在困难病例中更有效)。结肠清洗技术使肠道准备与标准的相当。这两种技术的结合可以提高结肠镜检查程序的接受度和对CCR筛查计划的依从性。
{"title":"Robotic Colonoscopy Endotics with Colon Wash: Two Performing Technologies in a Winning Combination","authors":"F. Cosentino, A. Rigante, R. Barbera, R. Giuberti, R. Tinelli, S. Zanardi","doi":"10.47690/WJGHE.2021.3401","DOIUrl":"https://doi.org/10.47690/WJGHE.2021.3401","url":null,"abstract":"BACKGROUND: Colonoscopy is the standard method for CCR prevention, diagnosis, and treatment, but it is painful and highly dependent on quality of bowel preparation. This study describes the experience of the first 150 colonoscopies performed using the Endotics System at S. Giuseppe Hospital in Milan (Italy), demonstrating the effectiveness, diagnostic quality, and lack of pain even without sedation. Moreover, at the patient's request, robotic system was combined with Colon Wash technology, able to prepare the bowel in a comfortable and effective way without use of purgatives. METHODS: The study is observational, retrospective, comparative, on a group of 150 patients, enrolled consecutively over a year. Quality of the intestinal preparation is evaluated and then reported based on BBPS for both patients who underwent Colon Wash and those who opted for the traditional preparation. In addition, the total percentage of cecal intubation and the average time needed to achieve it, in patients who have also undergone Colon Wash, are reported. RESULTS: 87 out of the 150 patients enrolled, (58%) chose intestinal preparation with Colon Wash technology. In this group, optimal preparation was obtained in 71.3% of cases. The percentage of optimal preparation among patients who chose the traditional method decreased 66.7%. Failure rates of procedure due to poor bowel preparation were 4.6% and 3.2% respectively. Cecum was achieved in 99.2% of cases with an average time of 22.5 minutes. In addition, in patients with a previous failed conventional colonoscopy, cecum was achieved in 92.3% of cases. 58 patients out of the 150 were eligible for the ADR calculation according to the ASGE guidelines, resulting in an overall ADR of 39.7% (ADR M of 60% and ADR F of 24.2%). CONCLUSIONS: Endotics system confirms its ability to perform painless procedures as effectively as conventional colonoscopy (and Journal Home: https://scienceworldpublishing.org/journals/world-journal-of-gastroenterology-hepatology-and-endoscopy/WJGHE World J Gastroenterol Hepatol Endosc Volume: 3.4 2/9 more effectively in difficult cases). Colon Wash technology allows intestinal preparation comparable to the standard one. The combination of these two technologies can increase acceptance of colonoscopy procedure and adherence to CCR screening programs.","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"425 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72495569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Ramadan on crohn's disease 斋月对克罗恩病的影响
Pub Date : 2021-01-01 DOI: 10.15761/ghe.1000217
E. M, Benelbarhdadi I, Borahma M, Ajana Fz
{"title":"Impact of Ramadan on crohn's disease","authors":"E. M, Benelbarhdadi I, Borahma M, Ajana Fz","doi":"10.15761/ghe.1000217","DOIUrl":"https://doi.org/10.15761/ghe.1000217","url":null,"abstract":"","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73125666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
COVID-19 Induced Hepatitis (CIH), Definition and Diagnostic Criteria of a Poorly Understood New Clinical Syndrome COVID-19诱导肝炎(CIH),一种鲜为人知的新临床综合征的定义和诊断标准
Pub Date : 2020-09-01 DOI: 10.47690/wjghe.2020.3301
E. Gadour, Zeinab E. Hassan, Khalid Shrwani
Background Covid-19 Induced Hepatitis (CIH), is a novel terminology which is used in this article for the first time in the medical literature. Objective To study the pattern of liver impairment in patients with Covid-19 as well as to find acceptable and practical diagnostic criteria of Covid-19 Induced Hepatitis (CIH). This review article gives new insight and guidance about the diagnosis of Covid-19 Induced Hepatitis (CIH), possible causes of liver damage and review of recently published data about the impairment of liver function in Covid-19 patients. Methodology Extensive literature review of newly published data and study in PubMed cited journals and other international publisher journals. Research of all studies that reviewed liver derangement in COVID-19 were mainly reviewed. Statistical analysis of submitted data were checked using SPSS. PubMed Chinese language versions were also used. Results 60% of patients with SARS can have abnormal liver functions. Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) have noticeably been abnormal in around 14–53% of patients with Covid-19 (7/114, 6.14%) (P>0.05). Impairment in liver enzymes, mainly ALT/AST, in severe Covid-19 pneumonia was significantly higher than patients with mild disease, with mean average (37.87±32.17 vs 21.22± 12.67;38.87 ± 22.55 vs 24.39± 9.79, P Conclusion Covid-19 Induced Hepatitis (CIH) is a new clinical syndrome, which can be defined as a ‘benign new transient hepatitis in a SARS-CoV-2 patients which icharacterized by the following; Gradual onset, elevated AST and ALT, Dilated sinusoids with lymphocytic infiltration of liver parenchyma, non-Obstructive jaundice, stable Underlying liver disease and no Radiological new hepatobiliary changes.’ Using GADOUR criteria may support the diagnosis, however, sensitivity and specificity are yet to be established. Meticulous statistical studies need to be done before establishing overly sensitive scoring system can be reach.
背景Covid-19诱导肝炎(CIH)是医学文献中首次使用的一个新术语。目的探讨新型冠状病毒感染(Covid-19)患者的肝损害规律,寻求可接受的、实用的新型冠状病毒性肝炎(CIH)诊断标准。这篇综述文章对Covid-19诱导肝炎(CIH)的诊断、肝损伤的可能原因以及最近发表的关于Covid-19患者肝功能损害的数据进行了综述,提供了新的见解和指导。对PubMed引用期刊和其他国际出版商期刊上新发表的数据和研究进行广泛的文献综述。主要综述了所有涉及新冠肺炎肝损害的研究。对提交的数据进行SPSS统计分析。PubMed中文版也被使用。结果60%的SARS患者可出现肝功能异常。约14 ~ 53%的新冠肺炎患者存在谷草转氨酶(AST)和丙氨酸转氨酶(ALT)异常(7/114,6.14%)(P < 0.05)。重症肺炎患者以ALT/AST为主的肝酶损害显著高于轻症患者,平均(37.87±32.17 vs 21.22±12.67;38.87±22.55 vs 24.39±9.79)P结论CIH是一种新的临床综合征,可定义为SARS-CoV-2患者的“良性新一过性肝炎”,具有以下特点;逐渐发病,AST和ALT升高,窦状窦扩张伴肝实质淋巴细胞浸润,非梗阻性黄疸,稳定的潜在肝脏疾病,无影像学上新的肝胆改变。“使用GADOUR标准可能支持诊断,然而,敏感性和特异性尚未建立。”在建立过于敏感的评分系统之前,需要进行细致的统计研究。
{"title":"COVID-19 Induced Hepatitis (CIH), Definition and Diagnostic Criteria of a Poorly Understood New Clinical Syndrome","authors":"E. Gadour, Zeinab E. Hassan, Khalid Shrwani","doi":"10.47690/wjghe.2020.3301","DOIUrl":"https://doi.org/10.47690/wjghe.2020.3301","url":null,"abstract":"Background Covid-19 Induced Hepatitis (CIH), is a novel terminology which is used in this article for the first time in the medical literature. Objective To study the pattern of liver impairment in patients with Covid-19 as well as to find acceptable and practical diagnostic criteria of Covid-19 Induced Hepatitis (CIH). This review article gives new insight and guidance about the diagnosis of Covid-19 Induced Hepatitis (CIH), possible causes of liver damage and review of recently published data about the impairment of liver function in Covid-19 patients. Methodology Extensive literature review of newly published data and study in PubMed cited journals and other international publisher journals. Research of all studies that reviewed liver derangement in COVID-19 were mainly reviewed. Statistical analysis of submitted data were checked using SPSS. PubMed Chinese language versions were also used. Results 60% of patients with SARS can have abnormal liver functions. Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) have noticeably been abnormal in around 14–53% of patients with Covid-19 (7/114, 6.14%) (P>0.05). Impairment in liver enzymes, mainly ALT/AST, in severe Covid-19 pneumonia was significantly higher than patients with mild disease, with mean average (37.87±32.17 vs 21.22± 12.67;38.87 ± 22.55 vs 24.39± 9.79, P Conclusion Covid-19 Induced Hepatitis (CIH) is a new clinical syndrome, which can be defined as a ‘benign new transient hepatitis in a SARS-CoV-2 patients which icharacterized by the following; Gradual onset, elevated AST and ALT, Dilated sinusoids with lymphocytic infiltration of liver parenchyma, non-Obstructive jaundice, stable Underlying liver disease and no Radiological new hepatobiliary changes.’ Using GADOUR criteria may support the diagnosis, however, sensitivity and specificity are yet to be established. Meticulous statistical studies need to be done before establishing overly sensitive scoring system can be reach.","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"128 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74577473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
World journal of gastroenterology, hepatology and endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1